Stay updated with breaking news from Bio Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Path (NASDAQ:BPTH – Get Rating) and Chinook Therapeutics (NASDAQ:KDNY – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Analyst Ratings This is a summary of current ratings and […]
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note issued to investors on Tuesday. The firm issued a sell rating on the stock. Separately, Roth Capital reiterated a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Trading Down 1.7 % Shares of BPTH […]
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note released on Tuesday. The firm issued a sell rating on the stock. Separately, Roth Capital reaffirmed a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Trading Up 2.3 % Shares of BPTH stock opened […]
Wall Street brokerages expect Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) to report earnings per share of ($0.50) for the current quarter, according to Zacks. Zero analysts have made estimates for Bio-Path’s earnings. The highest EPS estimate is ($0.47) and the lowest is ($0.52). Bio-Path posted earnings of ($0.26) per share in the same quarter […]
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report issued on Saturday. The firm set a “sell” rating on the stock. A number of other analysts have also recently commented on BPTH. Zacks Investment Research cut shares of Bio-Path from a “hold” rating to a “sell” rating in a […]